Pre-emptive Analgesia Using Nebulized Ketamine Versus Nebulized Dexmedetomidine in Endoscopic Nasal Surgeries
Recruiting now · Not applicable
Conditions studied: Nose Diseases
In brief
this study aims to compare the efficacy of pre-emptive nebulized ketamine versus nebulized dexmedetomidine for post operative pain relief in endoscopic nasal surgery
Key facts
- Study ID
- NCT07056582
- Run by
- Sohag University
- People needed
- 105
- Starts
- 2025-04-14
- Expected to finish
- 2025-10-20
- Last updated by the study team
- 2025-07-09
Who can join
Age: 20 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients between the ages of 20 and 60,
- both sexes,
- American Society of Anesthesiologists physical status I to II
- BMI ≥18≤30 kg/m²
You may not qualify if…
- Patient refusal.
- patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
- patients with a history of allergies to any study drugs.
- patients who had used central nervous system depressants or analgesics within the previous 24 hours.
- patients with hypertension, hypotension, or bradycardia.
Where it is running
- Sohag university hospital — Sohag, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.